COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,387 Articles (22,816 medRxiv, 8,571 bioRxiv)

Most recent first Previous |  Page 612: Articles 6111-6120  | Next

SARS-CoV2 E and 3a proteins are inducers of pannexin currents
Oliveira Mendes, B., Alameh, M., Ollivier, B., Montnach, J., Bidere, N., Souaze, F., Escriou, N., Charpentier, F., Baro, I., De Waard, M., Loussouarn, G.
10.1101/2022.10.20.513002 — Posted: 2022-10-20
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
Rouet, R., Henry, J. Y., Johansen, M. D., Sobti, M., Balachandran, H., Langley, D. B., Walker, G., Lenthall, H., Jackson, J., Ubiparipovic, S., Mazigi, O., Schofield, P., Burnett, D. L., Brown, S. H. J., Martinello, M., Hudson, B., Gilroy, N., Post, J. J., Kelleher, A., Jäck, H.-M., Goodnow, C., Turville, S. G., Rawlinson, W. D., Bull, R. A., Stewart, A. G., Hansbro, P. M., Christ, D.
10.1101/2022.10.19.512954 — Posted: 2022-10-20
De novo design of anti-variant COVID vaccine with T-cell memory
Goswami, A., Kumar, M. S., Gore, M. M.
10.1101/2022.10.20.513049 — Posted: 2022-10-20
Intra-host viral populations of SARS-CoV-2 in immunosuppressed patients with hematologic cancers
Fournelle, D., Mostefai, F., Brunet-Ratnasingham, E., Poujol, R., Grenier, J.-C., Galvez, J. H., Pagliuzza, A., Levade, I., Moreira, S., Grandjean Lapierre, S., Chomont, N., Kaufmann, D. E., Craig, M., Hussin, J.
10.1101/2022.10.19.512884 — Posted: 2022-10-20
Endonuclease fingerprint indicates a synthetic origin of SARS-CoV-2
Bruttel, V., Washburne, A., VanDongen, A.
10.1101/2022.10.18.512756 — Posted: 2022-10-20
The humoral and cellular immune response of a third dose adenoviral-based vectored vaccine after a single or 2 shots of inactivated COVID-19 vaccine in healthy adults.
Suparak, S., Bumroongthai, K., Jantapalaboon, D., Phairoh, P., Wongkidakarn, S., Yodtup, C., Puangtubtim, W., Pimpapai, W., Soonthornchattrawat, S., Dhepaksorn, P., Mahasirimongkol, S.
10.1101/2022.10.18.512323 — Posted: 2022-10-19
Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
Kehrer, T., Cupic, A., Ye, C., Yildiz, S., Bouhhadou, M., Crossland, N. A., Barrall, E., Cohen, P., Tseng, A., Cagatay, T., Rathnasinghe, R., Flores, D., Jangra, S., Alam, F., Mena, N., Aslam, S., Saqi, A., Marin, A., Rutkowska, M., Ummadi, M. R., Pisanelli, G., Richardson, R. B., Veit, E. C., Fabius, J. M. A., Soucheray, M., Polacco, B. J., Evans, M. J., Swaney, D. L., Gonzalez-Reiche, A. S., Sordillo, E. M., van Bakel, H., Simon, V., Zuliani-Alvarez, L., Fontoura, B. M. A., Rosenberg, B. R., Krogan, N. J., Martinez-Sobrido, L., Garcia-Sastre, A., Miorin, L.
10.1101/2022.10.18.512708 — Posted: 2022-10-19
Regional epidemic dynamics and Delta variant diversity resulted in varying rates of spread of Omicron-BA.1 in Mexico
Zarate, S., Taboada, B., Rosales-Rivera, M., Garcia-Lopez, R., Munoz-Medina, J. E., Sanchez-Flores, A., Herrera-Estrella, A., Gomez-Gil, B., Mojica, N. S., Salas-Lais, A. G., Vazquez-Perez, J. A., Cabrera-Gaytan, D. A., Fernandes-Matano, L., Uribe-Noguez, L. A., Chale-Dzul, J. B., Maldonado Meza, B. I., Mejia-Nepomuceno, F., Perez-Padilla, R., Gutierrez-Rios, R. M., Loza, A., Lopez, S., Arias, C. F.
10.1101/2022.10.18.512746 — Posted: 2022-10-19
A collaborative approach to improving representation in viral genomic surveillance
Kim, P., Kim, A. Y., Newman, J. J., Cella, E., Bishop, T. C., Huwe, P. J., Uchakina, O. N., McKallip, R. J., Mack, V. L., Hill, M. P., Ogungbe, I. V., Adeyinka, O., Jones, S., Ware, G., Carroll, J. L., Sawyer, J. F., Densmore, K. H., Foster, M., Valmond, L., Thomas, J., Azarian, T., Queen, K., Kamil, J. P.
10.1101/2022.10.19.512816 — Posted: 2022-10-19
Interim Analysis of a Phase I Randomized Clinical Trial on the Safety and Immunogenicity of the mRNA-1283 SARS-CoV-2 Vaccine in Adults
Yassini, P., Hutchens, M., Paila, Y. D., Schoch, L., Aunins, A., Siangphoe, U., Paris, R.
10.1101/2022.10.18.22281050 — Posted: 2022-10-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).